Ring Therapeutics Announces Three Presentations at the 41st Annual Meeting of the American Society for Virology (ASV)
July 18, 2022 08:00 ET
|
Ring Therapeutics
CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today...
Ring Therapeutics Publishes the First Human Anellovirus Structure with Key Insights on Its Assembly, Function and Immune Evasion Properties
July 06, 2022 08:00 ET
|
Ring Therapeutics
– New data describe the first structure of anellovirus particles, including a novel jelly roll domain architecture – – Structural analyses suggest mechanism of anellovirus immune evasion that may...
Ring Therapeutics Announces Two Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 03, 2022 08:00 ET
|
Ring Therapeutics
CAMBRIDGE, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its AnellogyTM commensal virome...
Ring Therapeutics Announces Publication Highlighting In Vivo Delivery and Tropism of the First Synthesized Human Anelloviruses Using a Recombinant Genome
May 02, 2022 08:00 ET
|
Ring Therapeutics
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its AnellogyTM commensal virome...
Ring Therapeutics Announces Publication Highlighting the Immune Favorability of Commensal Anelloviruses
March 31, 2022 08:00 ET
|
Ring Therapeutics
– First description of new, comprehensive anellovirus antibody analysis tool, AnelloScan – – Cross-sectional study supports that anelloviruses are associated with weaker immune responses compared...
Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors
March 17, 2022 08:00 ET
|
Ring Therapeutics
CAMBRIDGE, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today...
Ring Therapeutics Strengthens Leadership Team with Three Executive Appointments
November 08, 2021 08:00 ET
|
Ring Therapeutics
BOSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today announced...
Ring Therapeutics to Present Data on Anellogy Platform at the ESGCT 28th Annual Congress
October 19, 2021 08:00 ET
|
Ring Therapeutics
CAMBRIDGE, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Ring Therapeutics (“Ring”), a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome...
Fierce Biotech names Ring Therapeutics as one of its “Fierce 15” Biotech Companies of 2021
September 27, 2021 08:00 ET
|
Ring Therapeutics
CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ring Therapeutics today announced that Fierce Biotech has named it as one of 2021’s Fierce 15 biotechnology companies, designating it as one of...